Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.
This study aimed to assess the clinical utility of PCR for the analysis of bacteria and fungi from blood for the management of febrile neutropenic patients with hematologic malignancies. Using a PCR system able to detect a broad range of bacteria and fungi, we conducted a prospective pilot study of periodic analyses of blood from patients following intensive chemotherapy. When fever occurred, it was treated with empirical antibiotic therapy, basically without knowledge of the PCR results. In 23 febrile episodes during the neutropenic period, bacteria were detected by PCR in 11 cases, while the same species were identified by blood culture in 3 cases. In 10 out of 11 PCR-positive cases, fever could be managed by empirical therapy. In the empirical-therapy-resistant case, the identification of Stenotrophomonas maltophilia by PCR led to improvement of fever. No fungi were detected by PCR in febrile cases, while Aspergillus fumigatus was detected in one afebrile patient, several days before a clinical diagnosis was made. In subsequent sporadic PCR analyses in 15 cases of febrile neutropenia, bacteria were detected by both PCR and blood culture in 7 cases and by PCR alone in 6. Fungi were not detected. While fever was improved by empirical therapy in 12 out of the 13 PCR-positive cases, the identification of Pseudomonas aeruginosa by PCR in one therapy-resistant case contributed to the successful treatment of persistent fever. Our results indicate that PCR analysis of bacteria from blood provides essential information for managing empirical-therapy-resistant febrile neutropenia.
Nakamura
Akiko
A
Central Clinical Laboratories, Mie University Hospital, Mie, Japan.
Sugimoto
Yuka
Y
Ohishi
Kohshi
K
Sugawara
Yumiko
Y
Fujieda
Atsushi
A
Monma
Fumihiko
F
Suzuki
Kei
K
Masuya
Masahiro
M
Nakase
Kazunori
K
Matsushima
Yoshiko
Y
Wada
Hideo
H
Katayama
Naoyuki
N
Nobori
Tsutomu
T
D000328:Adult; D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001419:Bacteria / Q000145:classification / Q000235:genetics / Q000302:isolation & purification; D001424:Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D001769:Blood / Q000382:microbiology*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005335:Fever of Unknown Origin / Q000209:etiology*; D005658:Fungi / Q000235:genetics / Q000302:isolation & purification; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis* / Q000382:microbiology; D009503:Neutropenia / Q000139:chemically induced / Q000276:immunology*; D016133:Polymerase Chain Reaction / Q000379:methods*; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents
Br J Haematol. 2006 Feb;132(4):478-86
16412020
J Clin Microbiol. 2009 Apr;47(4):877-84
19073865
Eur J Cancer. 2009 Sep;45(14):2462-72
19467584
N Engl J Med. 1993 May 6;328(18):1323-32
8469254
Clin Microbiol Infect. 2009 Jun;15(6):544-51
19392905
J Clin Microbiol. 2009 Feb;47(2):379-84
19109479
Arch Intern Med. 1985 Sep;145(9):1621-9
3927867
Cancer. 1972 Aug;30(2):573-9
5051680
Clin Infect Dis. 2004 Jul 15;39 Suppl 1:S44-8
15250020
Med Microbiol Immunol. 2008 Sep;197(3):313-24
18008085
Curr Opin Hematol. 2009 Jan;16(1):48-52
19057204
Clin Infect Dis. 2007 Dec 15;45(12):1602-9
18190323
Clin Infect Dis. 2002 Mar 15;34(6):730-51
11850858
Br J Haematol. 2000 Nov;111(2):635-40
11122112
J Med Microbiol. 2008 May;57(Pt 5):601-604
18436593
Lancet. 2002 Mar 2;359(9308):723-5
11888579
Med Mycol. 2006 Dec;44(8):733-9
17127630
Int J Antimicrob Agents. 2007 May;29(5):501-9
17346939
Cancer. 2002 Feb 15;94(4):1032-6
11920473
Leuk Lymphoma. 2004 Aug;45(8):1637-41
15370218
N Engl J Med. 1971 May 13;284(19):1061-5
4994878
Infection. 2008 Dec;36(6):580-4
18854937
Clin Microbiol Infect. 2008 Apr;14 Suppl 3:22-31
18318876
Hematol Oncol. 2006 Sep;24(3):120-5
16783844
Shock. 2009 Jun;31(6):586-91
19060784
Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):229-37
17334747
Clin Infect Dis. 2001 Nov 1;33(9):1504-12
11588697
Lancet Infect Dis. 2009 Feb;9(2):89-96
19179225
Cancer. 2005 Mar 15;103(6):1103-13
15666328
Clin Microbiol Infect. 2008 May;14 Suppl 4:37-45
18430128
J Clin Microbiol. 2009 Jul;47(7):2340-3
19458178
J Clin Microbiol. 2007 Nov;45(11):3743-53
17715373
J Clin Microbiol. 2009 Sep;47(9):2759-65
19571030
Bone Marrow Transplant. 2000 Sep;26(5):533-8
11019843
J Clin Microbiol. 2009 Aug;47(8):2405-10
19571034
J Antimicrob Chemother. 2008 Nov;62(5):889-94
18662945
Med Mycol. 2009;47 Suppl 1:S223-32
18608902
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
18462102
Clin Microbiol Infect. 2005 Oct;11(10):778-87
16153251
Curr Opin Infect Dis. 2009 Aug;22(4):385-93
19506476